OHSU scientists first to successfully create primate embryonic stem cells
On Nov. 14, 2007, researchers at OHSU’s Oregon National Primate Research Center announced they had successfully derived embryonic…
Alain Carpentier in Paris and Albert Starr in Portland, Oregon received Albert Lasker Award for Clinical Medical Research
On Sept. 15, 1997, Alain Carpentier at Hospital European Goerges Pompidou in Paris and Albert Starr at Providence…
Leadership gift of $5.5 million from Harold & Arlene Schnitzer CARE Foundation established new diabetes health center at OHSU
On Jul. 11, 2007, Oregon Health & Science University (OHSU) announced a leadership gift of $5.5 million from…
Oregon philanthropist Hallie Ford gave a gift of $8 million to Oregon State University’s College of Health and Human Sciences
On Jun. 14, 2007, Hallie Ford, a noted Oregon philanthropist, made a gift of $8 million to Oregon…
Dr. Bagby retired as OHSU director and Brian Druker, MD was named his successor
On May 21, 2007, Oregon Health & Science University (OHSU) announced that Grover Bagby, M.D., after 15 years…
OHSU-Led alcohol research consortium received $24 million NIAAA grant
On Mar. 20, 2007, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced a five-year, $24 million…
OHSU received $40 million donation from an anonymous donor
On Feb. 8, 2007, OHSU and the OHSU Foundation announced the largest outright gift in the institution’s 120-year…
The Oregon Translational Research and Drug Discovery Institute at Oregon State University was founded
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
The FDA approved Gleevec, a drug developed by the OHSU Cancer Institute, for five cancers
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
OHSU’s Peter O Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill
In 2006, The OHSU Peter O. Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill in…
The National Cancer Institute approved a $10 million award for OHSU Cancer Institute
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
OHSU Clinical Outcomes Research Initiative received $2.5 million NIH grant
On Dec. 20, 2004, the Clinical Outcomes Research Initiative (CORI) based at OHSU anounnced it had received a…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Pacific Northwest team unveiled the largest virus proteome to date
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress
National Institutes of Health opened the Mark O Hatfield Clinical Research Center
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Schnitzer Investment Corporation donated nearly 20 acres of riverfront property in South Waterfront to OHSU
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Ophthalmogy | Therapeutics
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Ophthalmogy
OHSU researcher uncovered macular degeneration gene
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
First West Coast Baby born using frozen egg technique at OHSU
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
Molecular Probes was acquired by Invitrogen Corp
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
The Oregon Investment Fund was established
In Jul. 2003, HB 3613 was passed in the Oregon State Legislature and enacted a mandate for the…
OHSU broke ground on new biomedical research building
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
Oregon Health & Science University merged with Oregon Graduate Institute of Science and Technology
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
OHSU researchers produced the first genetically modified monkey
On Jan 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…